Senseonics Holdings, Inc. (SENS)
USD 0.74
(6.36%)
USD 0.74
(6.36%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -48 Million USD | -11.09% |
| 2022 | 161.8 Million USD | -17.14% |
| 2021 | -284.51 Million USD | 37.95% |
| 2020 | -157.86 Million USD | 30.57% |
| 2019 | -99.4 Million USD | -54.35% |
| 2018 | -85.41 Million USD | -54.01% |
| 2017 | -55.77 Million USD | -32.25% |
| 2016 | -42.17 Million USD | -47.15% |
| 2015 | -28.65 Million USD | -54.8% |
| 2014 | -18.51 Million USD | 0.3% |
| 2013 | -18.56 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 FY | - USD | -11.09% |
| 2023 Q1 | -17.54 Million USD | 3.5% |
| 2023 Q4 | -19.14 Million USD | -6.01% |
| 2023 Q3 | -18.06 Million USD | -10.36% |
| 2023 Q2 | -16.36 Million USD | 6.72% |
| 2022 Q2 | -17.9 Million USD | -6.36% |
| 2022 Q3 | -18.57 Million USD | -3.76% |
| 2022 Q4 | -18.18 Million USD | 2.12% |
| 2022 Q1 | -16.83 Million USD | -1.48% |
| 2022 FY | - USD | -17.14% |
| 2021 Q3 | -14.82 Million USD | -9.22% |
| 2021 Q2 | -13.57 Million USD | 13.42% |
| 2021 Q4 | -16.59 Million USD | -11.91% |
| 2021 Q1 | -15.67 Million USD | 0.77% |
| 2021 FY | - USD | 37.95% |
| 2020 Q1 | -13.5 Million USD | -7.76% |
| 2020 Q4 | -15.8 Million USD | -42.16% |
| 2020 FY | - USD | 30.57% |
| 2020 Q2 | -22.31 Million USD | -65.22% |
| 2020 Q3 | -11.11 Million USD | 50.19% |
| 2019 Q1 | -34.82 Million USD | -3.1% |
| 2019 FY | - USD | -54.35% |
| 2019 Q4 | -12.53 Million USD | 71.32% |
| 2019 Q3 | -43.69 Million USD | -28.68% |
| 2019 Q2 | -33.95 Million USD | 2.5% |
| 2018 Q2 | -27.85 Million USD | -25.92% |
| 2018 Q1 | -22.12 Million USD | -10.39% |
| 2018 Q3 | -29.2 Million USD | -4.82% |
| 2018 Q4 | -33.78 Million USD | -15.67% |
| 2018 FY | - USD | -54.01% |
| 2017 Q3 | -20.45 Million USD | -32.29% |
| 2017 FY | - USD | -32.25% |
| 2017 Q4 | -20.04 Million USD | 2.0% |
| 2017 Q2 | -15.45 Million USD | 5.8% |
| 2017 Q1 | -16.41 Million USD | -41.99% |
| 2016 Q2 | -9.36 Million USD | 9.48% |
| 2016 Q1 | -10.34 Million USD | 10.54% |
| 2016 Q3 | -12.34 Million USD | -31.89% |
| 2016 Q4 | -11.55 Million USD | 6.38% |
| 2016 FY | - USD | -47.15% |
| 2015 FY | - USD | -54.8% |
| 2015 Q1 | -1759.00 USD | 95.78% |
| 2015 Q2 | -8.16 Million USD | -463856.79% |
| 2015 Q3 | -10.91 Million USD | -33.7% |
| 2015 Q4 | -11.55 Million USD | -5.94% |
| 2014 FY | - USD | 0.3% |
| 2014 Q3 | -1659.00 USD | 36.94% |
| 2014 Q4 | -41.64 Thousand USD | -2410.37% |
| 2014 Q1 | -21.65 Thousand USD | 0.0% |
| 2014 Q2 | -2631.00 USD | 87.85% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -14.83 Million USD | -223.527% |
| Electromed, Inc. | 7.42 Million USD | 746.793% |
| Catheter Precision, Inc. | -15.11 Million USD | -217.704% |
| Xtant Medical Holdings, Inc. | -6.98 Million USD | -587.357% |